Recently, the Industry and Information Technology Bureau of Pingshan District, Shenzhen, announced the list of 2023 innovative small and medium-sized enterprises (SMEs) in Pingshan District, and Shenzhen Cell Valley was approved as an innovative SME.

Innovative SMEs possess a relatively high level of specialization, strong innovation capabilities, and development potential, serving as the foundation and backbone of high-quality SMEs. These enterprises take technological innovation as their core and develop comprehensive and sustained innovation capabilities spanning technology, brand, systems, management, and culture. This designation is regarded as a "certification" mark of an enterprise's innovation capability. The comprehensive uation focuses on strict assessment and verification across three major dimensions: innovation capability, growth potential, and specialization. Shenzhen Cell Valley successfully passed the selection and was approved as an innovative SME based on its innovative technologies, team strength, and industry-leading products and services. This represents recognition of Shenzhen Cell Valley by uation experts from all sectors and encourages the company to continue upholding technological innovation and leading the future. Shenzhen Cell Valley will continue to be dedicated to providing full-industry-chain services from early-stage R&D, clinical research, and talent cultivation to contract manufacturing and new drug applications, leveraging its professional advantages to truly benefit cancer patients and contribute to the development of the biopharmaceutical field.